Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
 

Search in our Online Store

Financials
Filter     Order     Display # 
Date Item Title
31 Jan 2008 Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
30 Jan 2008 Record operating results for Roche again in 2007
30 Jan 2008 Merck Announces 2007 Financial Results Reflecting Revenue Growth from Key Products
29 Jan 2008 Trimeris Reports 2007 FUZEON(R) Sales Results
29 Jan 2008 Lilly Caps Successful Year with Strong Fourth-Quarter Results
29 Jan 2008 Amylin Pharmaceuticals Reports 2007 Financial Results
28 Jan 2008 Abbott and Eisai Announce Changes in the Sales Scheme in Japan for Adalimumab, A Fully Human Monoclonal Anti-TNF-alpha Antibody
25 Jan 2008 Abbott Reports 16.1 Percent Sales Growth in Fourth Quarter
25 Jan 2008 Gilead Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
24 Jan 2008 Pfizer Reports Fourth-Quarter and Full-Year 2007 Results and 2008 Financial Guidance
24 Jan 2008 Amgen's Fourth Quarter 2007 Adjusted Earnings Per Share (EPS) Increased 11 Percent to $1.00; Full Year 2007 Adjusted EPS Increased 10 Percent to $4.29
22 Jan 2008 Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
22 Jan 2008 Johnson & Johnson Reports Fourth-Quarter and Year-End 2007 Financial Results
18 Jan 2008 Roche invests 430 million Swiss francs at sites in Germany and Switzerland
17 Jan 2008 Novartis achieves record results in 2007 underscoring benefits of strategic healthcare portfolio
10 Jan 2008 Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
10 Jan 2008 Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
07 Jan 2008 MediGene Focuses its Research Activities and Considers External Financing for mTCR Program
26 Dec 2007 Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
17 Dec 2007 Management Board and Supervisory Board publish statement on the mandatory offer of Santo Holding
12 Dec 2007 AstraZeneca Files Patent Infringement Actions in Response to Crestor(TM) ANDAs
29 Nov 2007 "Biotechnology made in Biberach": Expansion of biopharmaceutical production plant further strengthens Boehringer Ingelheim's expertise in biotechnology
15 Nov 2007 Johnson & Johnson Announces Changes to Accelerate Growth
14 Nov 2007 Roche Confirms Commencement of Due Diligence with Ventana
07 Nov 2007 Glenmark announces plan to reorganize businesses into Specialty and Generics
05 Nov 2007 Transition Therapeutics Provides Update on Diabetes Program
24 Oct 2007 Jury Rules Roche Infringes Amgen's EPO Patents
09 Oct 2007 Reinforcing strategic focus on growth-driving global products
20 Sep 2007 Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
11 Sep 2007 Antobody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing From Aescap Venture and Atlas Venture
08 Sep 2007 Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics
04 Sep 2007 Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
04 Sep 2007 European Centre for Modern Drug Discovery Established in Hamburg
29 Aug 2007 Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents
27 Aug 2007 Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
16 Aug 2007 Amgen restructures due to lower Aranesp(R) revenues while continuing to invest in innovation and future growth
15 Aug 2007 SciGen and Ferring International terminate relationship
13 Aug 2007 BioMarin partner AnGes MG, Inc. submits BLA to Japanese Ministry of Health
13 Aug 2007 Roche and Actavis agree on product transactions
12 Aug 2007 Novartis withdraws Prexige(R) (lumiracoxib) in Australia in response to
11 Aug 2007 UK High Court ruled NICE Guidence for Alzheimer's disease discriminatory
 
<< Start < Prev 1 2 Next > End >>
Results 51 - 91 of 91

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics